Amorpha-4,11-diene: Difference between revisions
CSV import |
No edit summary |
||
| Line 20: | Line 20: | ||
{{medicine-stub}} | {{medicine-stub}} | ||
<gallery> | <gallery> | ||
File:Amorpha-4,11-diene.svg|Amorpha-4,11-diene | File:Amorpha-4,11-diene.svg|Amorpha-4,11-diene | ||
</gallery> | </gallery> | ||
Latest revision as of 19:02, 16 March 2025
Amorpha-4,11-diene is a sesquiterpene that is a key intermediate in the biosynthesis of the antimalarial drug artemisinin. It is produced by the plant Artemisia annua, also known as sweet wormwood or annual mugwort.
Biosynthesis[edit]
The biosynthesis of amorpha-4,11-diene begins with the conversion of farnesyl pyrophosphate (FPP) into amorpha-4,11-diene by the enzyme amorpha-4,11-diene synthase. This reaction is a part of the mevalonate pathway, which is responsible for the production of many different types of terpenes and terpenoids.
Role in Artemisinin Production[edit]
Amorpha-4,11-diene is a precursor to artemisinic acid, which is then converted into dihydroartemisinic acid before finally being transformed into artemisinin. The conversion of amorpha-4,11-diene to artemisinic acid is catalyzed by a series of enzymes, including cytochrome P450 enzymes and a reductase.
Biotechnological Production[edit]
Due to the importance of artemisinin in the treatment of malaria, there has been significant interest in developing biotechnological methods for producing amorpha-4,11-diene. This has included the genetic modification of yeast and E. coli to produce the compound. These methods have the potential to provide a more sustainable and cost-effective source of artemisinin than traditional plant-based methods.
See Also[edit]
This article is a medical stub. You can help WikiMD by expanding it!
-
Amorpha-4,11-diene